BioNTech to Present at 35th Annual J.P. Morgan Healthcare Conference 2017

Mainz, Germany, 22nd December 2016: BioNTech AG, a fully integrated biotechnology company developing truly individualized cancer immunotherapies, today announced that Sean Marett, COO of BioNTech, will be presenting at 35th Annual J.P. Morgan Healthcare Conference that is being held in San Francisco, CA January 9 – 12, 2017. The presentation is scheduled for Wednesday, January 11th at 9:30 AM Pacific Standard Time. Mr. Marett will provide an overview of the company´s strategy and its most recent substantial progress, including an update of its clinical pipeline, an overview of its strategic collaborations, a summary of its two most recent Nature publications related to its individualized mRNA cancer vaccines and the establishment of a second mRNA production facility at the Company´s headquarters in Germany.

The J.P. Morgan Healthcare Conference brings together corporate leaders, financial sponsors and institutional investors to explore market and sector trends.

For meeting requests or further information, please contact:                

General Inqriries
Regina Jehle
BioNTech AG
Phone: +49 6131 9084 1273
Email: Regina.Jehle@biontech.de

Investors
ICR, Inc.
Stephanie Carrington
Phone: +1 646-277-1282
Email: Stephanie.Carrington@icrinc.com

Media
ICR, Inc.
James Heins
Phone: +1 203-682-8251
Email: James.Heins@icrinc.com

*** Announcement in English – PDF ***